However, growing evidences show that IL-17 promotes tumor growth in various solid tumors, including melanoma, breast cancer, colon cancer, and hepatocellular carcinoma (Wang et al., 2009; Grivennikov et al., 2012; Coffelt et al., 2015; Gomes et al., 2016). Here, IL17A is linked to breast cancer.